Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-17.31	47.27	57.17
Graham Fair Price	-32.65	3200.27	4751.36
PEG	15.95	0.14	0.12
Price/Book	0.32	0.44	0.43
Price/Cash Flow	-200.64	-9.82	-3.27
Prices/Earnings	-114.41	-7.48	-3.49
Price/Sales	-4.02	0.68	0.71
Price/FCF	-200.64	-9.82	-3.27
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	10.31	0.15	0.13
Operating Margin	-91.41	< 0.005	-0.02
ROA	55.67	< 0.005	-0.01
ROE	-0.03	-0.01	53.21
ROIC	< 0.005	< 0.005	-91.81
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.09	0.06	51.52
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	0.67	1.09	63.46
EPS QOQ	0.29	0.54	84.92
FCF QOQ	-2.99	0.67	-77.52
Revenue QOQ	0.03	0.03	7.90
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	46.92	45.93	-2.11
Days Sales Outstanding (DSO)	45.11	47.70	5.74
Inventory Turnover	1.92	1.96	2.15
Debt/Capitalization	0.59	0.62	4.36
Quick Ratio	0.38	0.45	17.20
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	5682.24	5595.30	-1.53
Cash	1121.23	1573.87	40.37
Capex	-68.11	-206.74	-203.55
Free Cash Flow	-754.63	-247.95	67.14
Revenue	3464.23	3565.56	2.92
Naive Interpretation	member

05 - Per Share Metrics · Best

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	0.60	0.67	10.50
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	43.37	36.36	-16.17
Naive Interpretation	Member

06 - Financial Health · Bad

Rating